Veolia's $27 billion hazardous waste warning: real regional gap, self-serving headline

Veolia commissioned Charles River Associates to model U.S. hazardous waste growth. The result, released in September 2026, frames treatment capacity as critical infrastructure for the manufacturing boom. Veolia is also one of the world's largest hazardous waste treatment companies.

• Generation could reach 37.4 million tons by 2033, up 5 million from 2023.
• Manufacturing produces 90% of it, with new semiconductor, pharma, steel, auto and biotech plants driving growth.
• A 1% capacity shortfall could cut 2033 real gross output by $27 billion; 3% by $82 billion.
• Sector revenue nearly tripled, from $3.6 billion (2021) to almost $9 billion (2023).

Capacity is geographically concentrated. New manufacturing hubs — fabs in Arizona, battery plants in the Southeast — may be far from existing incinerators, landfills and deep wells. Hazardous waste does not travel cheaply. Treating capacity planning as part of industrial strategy is a sound idea.

• Conflict of interest. A treatment company funded a report concluding the country needs more treatment.
• National vs regional. The report does not separate total national capacity (probably adequate) from regional gaps (plausible) — which is the one distinction that matters.
• Revenue is not volume. Tripling revenue may reflect price rises and consolidation as much as tonnage.
• Advocacy tone. "$27 Billion at Stake" is a lobbying headline.

Not "is there enough capacity?" but "is there enough of the right treatment type within economic haul distance of where new plants are being built?" That needs regional data EPA and states can produce independently. Until then, read this report as an industry case for permits — informed by a real issue, but not neutral.